Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polymorphism, Single Nucleotide | 218 | 2019 | 1079 | 9.810 |
Why?
|
Genetic Predisposition to Disease | 172 | 2019 | 836 | 9.750 |
Why?
|
African Americans | 148 | 2019 | 1373 | 7.990 |
Why?
|
Lupus Erythematosus, Systemic | 61 | 2019 | 145 | 6.570 |
Why?
|
Diabetes Mellitus, Type 2 | 119 | 2019 | 1379 | 6.040 |
Why?
|
Genome-Wide Association Study | 94 | 2019 | 543 | 5.000 |
Why?
|
European Continental Ancestry Group | 92 | 2019 | 1131 | 4.210 |
Why?
|
Cerebral Hemorrhage | 27 | 2019 | 62 | 4.200 |
Why?
|
Kidney Failure, Chronic | 51 | 2019 | 518 | 3.970 |
Why?
|
Hispanic Americans | 67 | 2019 | 904 | 3.490 |
Why?
|
Genetic Variation | 36 | 2019 | 251 | 3.170 |
Why?
|
Apolipoproteins | 25 | 2016 | 196 | 3.170 |
Why?
|
Lipoproteins, HDL | 26 | 2018 | 247 | 3.130 |
Why?
|
Genotype | 121 | 2019 | 735 | 3.100 |
Why?
|
Diabetic Nephropathies | 35 | 2019 | 195 | 3.040 |
Why?
|
Humans | 402 | 2019 | 29093 | 2.930 |
Why?
|
Insulin Resistance | 38 | 2019 | 449 | 2.880 |
Why?
|
Middle Aged | 238 | 2019 | 10829 | 2.800 |
Why?
|
Female | 304 | 2019 | 18164 | 2.750 |
Why?
|
Male | 300 | 2019 | 17807 | 2.730 |
Why?
|
Case-Control Studies | 78 | 2019 | 859 | 2.310 |
Why?
|
Adult | 162 | 2019 | 8420 | 2.040 |
Why?
|
Lupus Nephritis | 9 | 2018 | 30 | 2.040 |
Why?
|
Aged | 158 | 2019 | 9487 | 2.000 |
Why?
|
Alleles | 45 | 2019 | 251 | 1.910 |
Why?
|
Haplotypes | 63 | 2018 | 220 | 1.890 |
Why?
|
Adiposity | 18 | 2018 | 191 | 1.800 |
Why?
|
Linkage Disequilibrium | 45 | 2019 | 192 | 1.780 |
Why?
|
Gene Frequency | 50 | 2019 | 225 | 1.740 |
Why?
|
Genetic Loci | 25 | 2019 | 147 | 1.670 |
Why?
|
African Continental Ancestry Group | 23 | 2019 | 350 | 1.670 |
Why?
|
Molecular Motor Proteins | 15 | 2015 | 58 | 1.620 |
Why?
|
Phenotype | 49 | 2019 | 629 | 1.610 |
Why?
|
Myosin Heavy Chains | 15 | 2015 | 86 | 1.610 |
Why?
|
Obesity | 22 | 2018 | 1063 | 1.570 |
Why?
|
Atherosclerosis | 24 | 2018 | 693 | 1.530 |
Why?
|
Membrane Proteins | 15 | 2019 | 256 | 1.520 |
Why?
|
Genome, Human | 20 | 2017 | 129 | 1.500 |
Why?
|
Cardiovascular Diseases | 23 | 2019 | 1013 | 1.480 |
Why?
|
Kidney Diseases | 16 | 2019 | 239 | 1.460 |
Why?
|
Quantitative Trait Loci | 23 | 2019 | 140 | 1.380 |
Why?
|
Genetic Association Studies | 28 | 2019 | 148 | 1.330 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2019 | 268 | 1.320 |
Why?
|
Adipose Tissue | 15 | 2019 | 327 | 1.310 |
Why?
|
Polymorphism, Genetic | 17 | 2018 | 196 | 1.280 |
Why?
|
Risk Factors | 75 | 2019 | 3531 | 1.240 |
Why?
|
Models, Genetic | 17 | 2018 | 92 | 1.210 |
Why?
|
Cohort Studies | 50 | 2018 | 1687 | 1.140 |
Why?
|
Continental Population Groups | 12 | 2019 | 221 | 1.100 |
Why?
|
Chromosome Mapping | 31 | 2019 | 190 | 1.080 |
Why?
|
Calcinosis | 16 | 2016 | 143 | 1.070 |
Why?
|
Bone Density | 12 | 2018 | 182 | 1.040 |
Why?
|
Adiponectin | 12 | 2017 | 103 | 1.030 |
Why?
|
Mexican Americans | 9 | 2019 | 59 | 0.930 |
Why?
|
Albuminuria | 16 | 2017 | 176 | 0.930 |
Why?
|
Aged, 80 and over | 45 | 2019 | 3717 | 0.900 |
Why?
|
Coronary Artery Disease | 15 | 2015 | 359 | 0.860 |
Why?
|
HLA Antigens | 5 | 2017 | 35 | 0.850 |
Why?
|
Adolescent | 37 | 2019 | 3254 | 0.840 |
Why?
|
Body Mass Index | 29 | 2018 | 865 | 0.830 |
Why?
|
American Native Continental Ancestry Group | 4 | 2017 | 13 | 0.820 |
Why?
|
Autoimmune Diseases | 4 | 2018 | 50 | 0.820 |
Why?
|
Chromosomes, Human, Pair 1 | 9 | 2016 | 35 | 0.800 |
Why?
|
Ethnic Groups | 13 | 2019 | 440 | 0.780 |
Why?
|
Lipids | 7 | 2019 | 209 | 0.780 |
Why?
|
Rheumatic Diseases | 2 | 2017 | 7 | 0.780 |
Why?
|
Renal Dialysis | 6 | 2017 | 259 | 0.760 |
Why?
|
Muscles | 2 | 2018 | 53 | 0.760 |
Why?
|
Blood Pressure | 13 | 2018 | 804 | 0.760 |
Why?
|
Young Adult | 30 | 2019 | 2402 | 0.750 |
Why?
|
Quantitative Trait, Heritable | 9 | 2019 | 47 | 0.750 |
Why?
|
Hypertension | 16 | 2019 | 906 | 0.750 |
Why?
|
Stroke | 9 | 2019 | 545 | 0.740 |
Why?
|
Disease Progression | 11 | 2019 | 572 | 0.730 |
Why?
|
Vitamin D | 9 | 2018 | 171 | 0.720 |
Why?
|
Insulin | 12 | 2018 | 346 | 0.710 |
Why?
|
Genomics | 4 | 2017 | 82 | 0.710 |
Why?
|
Blood Glucose | 13 | 2018 | 466 | 0.710 |
Why?
|
Carotid Artery Diseases | 10 | 2016 | 109 | 0.700 |
Why?
|
Arthritis, Rheumatoid | 5 | 2019 | 33 | 0.680 |
Why?
|
United States | 40 | 2019 | 3630 | 0.660 |
Why?
|
Glomerulosclerosis, Focal Segmental | 6 | 2018 | 36 | 0.660 |
Why?
|
Glomerular Filtration Rate | 13 | 2019 | 287 | 0.650 |
Why?
|
Cholesterol, HDL | 9 | 2019 | 165 | 0.650 |
Why?
|
Glucose | 12 | 2018 | 163 | 0.650 |
Why?
|
Genetic Markers | 16 | 2019 | 122 | 0.630 |
Why?
|
Genetic Load | 1 | 2017 | 4 | 0.620 |
Why?
|
Homeostasis | 16 | 2018 | 127 | 0.610 |
Why?
|
Genetics, Population | 5 | 2015 | 30 | 0.610 |
Why?
|
Diabetic Angiopathies | 8 | 2015 | 137 | 0.610 |
Why?
|
Gene Expression Regulation | 13 | 2018 | 481 | 0.600 |
Why?
|
Lipase | 3 | 2019 | 28 | 0.590 |
Why?
|
Logistic Models | 17 | 2018 | 727 | 0.560 |
Why?
|
Odds Ratio | 19 | 2017 | 447 | 0.550 |
Why?
|
Pedigree | 18 | 2018 | 133 | 0.540 |
Why?
|
Prospective Studies | 19 | 2019 | 2019 | 0.530 |
Why?
|
Cooperative Behavior | 2 | 2005 | 73 | 0.530 |
Why?
|
Triglycerides | 8 | 2019 | 214 | 0.520 |
Why?
|
Family | 15 | 2018 | 105 | 0.520 |
Why?
|
Alcoholism | 2 | 2005 | 95 | 0.510 |
Why?
|
JC Virus | 4 | 2019 | 23 | 0.500 |
Why?
|
Databases, Factual | 3 | 2017 | 332 | 0.490 |
Why?
|
DNA-Binding Proteins | 7 | 2016 | 142 | 0.480 |
Why?
|
Asian Continental Ancestry Group | 13 | 2019 | 110 | 0.480 |
Why?
|
Major Histocompatibility Complex | 5 | 2018 | 15 | 0.470 |
Why?
|
Intracellular Signaling Peptides and Proteins | 7 | 2017 | 72 | 0.470 |
Why?
|
C-Reactive Protein | 7 | 2018 | 232 | 0.470 |
Why?
|
Molecular Epidemiology | 2 | 2017 | 20 | 0.460 |
Why?
|
Lod Score | 20 | 2018 | 71 | 0.460 |
Why?
|
DNA Methylation | 3 | 2019 | 130 | 0.450 |
Why?
|
DNA | 10 | 2014 | 204 | 0.450 |
Why?
|
Tomography, X-Ray Computed | 16 | 2017 | 871 | 0.450 |
Why?
|
Genetic Diseases, Inborn | 2 | 2012 | 11 | 0.450 |
Why?
|
Age of Onset | 9 | 2017 | 95 | 0.450 |
Why?
|
Antibodies, Antinuclear | 5 | 2017 | 18 | 0.440 |
Why?
|
Promoter Regions, Genetic | 11 | 2019 | 212 | 0.440 |
Why?
|
Adaptor Proteins, Vesicular Transport | 2 | 2017 | 12 | 0.430 |
Why?
|
Decision Trees | 1 | 2012 | 23 | 0.420 |
Why?
|
Smoking | 8 | 2019 | 427 | 0.420 |
Why?
|
Vitamin D Deficiency | 5 | 2018 | 89 | 0.420 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 2 | 2012 | 2 | 0.420 |
Why?
|
Fatty Acid Desaturases | 3 | 2018 | 44 | 0.410 |
Why?
|
Chromosomes, Human, Pair 6 | 6 | 2016 | 20 | 0.400 |
Why?
|
Alcohol Drinking | 3 | 2019 | 244 | 0.400 |
Why?
|
Child | 18 | 2019 | 2219 | 0.400 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 103 | 0.400 |
Why?
|
Autoantibodies | 5 | 2019 | 41 | 0.390 |
Why?
|
Angiopoietin-1 | 1 | 2010 | 6 | 0.390 |
Why?
|
Chromosomes, Human, X | 2 | 2012 | 12 | 0.390 |
Why?
|
Epistasis, Genetic | 7 | 2018 | 44 | 0.390 |
Why?
|
Genetic Testing | 6 | 2009 | 90 | 0.390 |
Why?
|
Sequence Analysis, DNA | 10 | 2017 | 139 | 0.390 |
Why?
|
Chromosomes, Human, Pair 3 | 6 | 2012 | 28 | 0.380 |
Why?
|
Autoimmunity | 3 | 2019 | 26 | 0.370 |
Why?
|
Inflammation | 5 | 2019 | 507 | 0.370 |
Why?
|
Indians, North American | 6 | 2016 | 108 | 0.370 |
Why?
|
Adaptor Proteins, Signal Transducing | 6 | 2018 | 65 | 0.370 |
Why?
|
Interferon Regulatory Factors | 6 | 2017 | 12 | 0.350 |
Why?
|
Coronary Vessels | 7 | 2017 | 147 | 0.340 |
Why?
|
Sex Characteristics | 5 | 2013 | 167 | 0.340 |
Why?
|
Adipocytes | 3 | 2019 | 79 | 0.340 |
Why?
|
STAT4 Transcription Factor | 5 | 2018 | 16 | 0.330 |
Why?
|
Subcutaneous Fat | 4 | 2017 | 42 | 0.330 |
Why?
|
Carrier Proteins | 4 | 2018 | 131 | 0.330 |
Why?
|
Breast Neoplasms | 4 | 2019 | 666 | 0.330 |
Why?
|
Glaucoma, Open-Angle | 2 | 2018 | 17 | 0.330 |
Why?
|
Spine | 3 | 2018 | 38 | 0.330 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2016 | 200 | 0.320 |
Why?
|
STAT1 Transcription Factor | 3 | 2018 | 12 | 0.320 |
Why?
|
Introns | 12 | 2018 | 39 | 0.310 |
Why?
|
Cystitis, Interstitial | 2 | 2019 | 37 | 0.310 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 4 | 2016 | 14 | 0.310 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2019 | 62 | 0.310 |
Why?
|
Palliative Care | 2 | 2018 | 47 | 0.310 |
Why?
|
Aortic Diseases | 3 | 2016 | 54 | 0.310 |
Why?
|
Fatty Liver | 3 | 2013 | 66 | 0.310 |
Why?
|
Family Health | 12 | 2011 | 78 | 0.310 |
Why?
|
Apolipoproteins E | 3 | 2019 | 97 | 0.300 |
Why?
|
Genetics, Medical | 1 | 2007 | 3 | 0.300 |
Why?
|
Severity of Illness Index | 9 | 2017 | 863 | 0.300 |
Why?
|
Glomerulonephritis | 3 | 2018 | 21 | 0.300 |
Why?
|
Prognosis | 12 | 2019 | 1362 | 0.300 |
Why?
|
Cross-Sectional Studies | 15 | 2018 | 1356 | 0.300 |
Why?
|
Multigene Family | 3 | 2017 | 47 | 0.290 |
Why?
|
Multivariate Analysis | 11 | 2018 | 637 | 0.290 |
Why?
|
Fibroblast Growth Factors | 2 | 2017 | 34 | 0.290 |
Why?
|
Sex Factors | 9 | 2017 | 631 | 0.290 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2016 | 155 | 0.290 |
Why?
|
Cell Adhesion Molecules | 4 | 2019 | 45 | 0.280 |
Why?
|
Gene Expression Profiling | 6 | 2019 | 320 | 0.280 |
Why?
|
Tumor Virus Infections | 2 | 2018 | 20 | 0.280 |
Why?
|
Coronary Disease | 3 | 2018 | 200 | 0.280 |
Why?
|
Child, Preschool | 10 | 2019 | 1167 | 0.280 |
Why?
|
Polyomavirus Infections | 2 | 2018 | 21 | 0.280 |
Why?
|
Registries | 5 | 2016 | 278 | 0.280 |
Why?
|
Transcription Factors | 5 | 2019 | 172 | 0.280 |
Why?
|
Nephritis | 3 | 2015 | 14 | 0.270 |
Why?
|
Epigenesis, Genetic | 4 | 2019 | 98 | 0.270 |
Why?
|
Intracranial Aneurysm | 3 | 2012 | 55 | 0.270 |
Why?
|
Diabetes Complications | 8 | 2013 | 171 | 0.270 |
Why?
|
Computational Biology | 4 | 2019 | 86 | 0.270 |
Why?
|
Risk Assessment | 14 | 2019 | 1305 | 0.260 |
Why?
|
Nuclear Family | 4 | 2019 | 15 | 0.260 |
Why?
|
Intracranial Hemorrhage, Hypertensive | 2 | 2016 | 4 | 0.260 |
Why?
|
Chromosomes, Human, Pair 11 | 5 | 2018 | 24 | 0.260 |
Why?
|
Multifactorial Inheritance | 3 | 2017 | 19 | 0.250 |
Why?
|
Texas | 7 | 2014 | 35 | 0.250 |
Why?
|
Research Design | 2 | 2018 | 286 | 0.250 |
Why?
|
Prevalence | 10 | 2017 | 896 | 0.240 |
Why?
|
Tumor Suppressor Proteins | 3 | 2011 | 72 | 0.240 |
Why?
|
Tissue Donors | 2 | 2016 | 167 | 0.240 |
Why?
|
Hypertension, Renal | 2 | 2015 | 29 | 0.240 |
Why?
|
Graft Survival | 2 | 2016 | 228 | 0.240 |
Why?
|
Chromosomes, Human, Pair 16 | 3 | 2017 | 15 | 0.240 |
Why?
|
Postural Balance | 2 | 2016 | 160 | 0.240 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2004 | 46 | 0.240 |
Why?
|
Urine | 3 | 2019 | 59 | 0.240 |
Why?
|
Europe | 9 | 2019 | 77 | 0.240 |
Why?
|
Organ Size | 4 | 2017 | 196 | 0.240 |
Why?
|
Asthma | 4 | 2015 | 397 | 0.240 |
Why?
|
Risk | 8 | 2017 | 289 | 0.240 |
Why?
|
Anthropometry | 1 | 2003 | 82 | 0.240 |
Why?
|
Reproducibility of Results | 7 | 2019 | 726 | 0.230 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2015 | 10 | 0.230 |
Why?
|
Arteriosclerosis | 6 | 2005 | 116 | 0.230 |
Why?
|
Pesticides | 2 | 2016 | 189 | 0.230 |
Why?
|
Estrogen Receptor alpha | 3 | 2008 | 50 | 0.230 |
Why?
|
AIDS-Associated Nephropathy | 2 | 2015 | 11 | 0.230 |
Why?
|
Principal Component Analysis | 8 | 2016 | 60 | 0.230 |
Why?
|
Occupational Exposure | 2 | 2016 | 224 | 0.230 |
Why?
|
Genome | 5 | 2014 | 40 | 0.230 |
Why?
|
Kidney Transplantation | 3 | 2016 | 348 | 0.230 |
Why?
|
Muscle, Skeletal | 2 | 2019 | 494 | 0.230 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2014 | 12 | 0.230 |
Why?
|
Body Height | 3 | 2017 | 30 | 0.220 |
Why?
|
Emigrants and Immigrants | 2 | 2016 | 235 | 0.220 |
Why?
|
Body Fat Distribution | 2 | 2016 | 34 | 0.220 |
Why?
|
Colorado | 6 | 2014 | 40 | 0.220 |
Why?
|
Transients and Migrants | 2 | 2016 | 281 | 0.220 |
Why?
|
Cognition | 3 | 2016 | 526 | 0.220 |
Why?
|
Brain | 4 | 2017 | 930 | 0.220 |
Why?
|
Algorithms | 5 | 2016 | 462 | 0.220 |
Why?
|
Protein Tyrosine Phosphatases | 4 | 2006 | 17 | 0.210 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 48 | 0.210 |
Why?
|
KCNQ1 Potassium Channel | 2 | 2014 | 9 | 0.210 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2013 | 180 | 0.210 |
Why?
|
Body Composition | 4 | 2005 | 365 | 0.210 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2017 | 7 | 0.210 |
Why?
|
Urinary Tract Infections | 2 | 2019 | 36 | 0.210 |
Why?
|
Lipid Metabolism | 3 | 2019 | 100 | 0.210 |
Why?
|
Treatment Outcome | 10 | 2017 | 3099 | 0.210 |
Why?
|
Age Factors | 8 | 2017 | 1108 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2017 | 100 | 0.200 |
Why?
|
Brain Ischemia | 2 | 2017 | 136 | 0.200 |
Why?
|
Follow-Up Studies | 9 | 2018 | 2108 | 0.200 |
Why?
|
Pericardium | 3 | 2010 | 50 | 0.200 |
Why?
|
Glucose Tolerance Test | 6 | 2016 | 125 | 0.200 |
Why?
|
Apolipoprotein E2 | 2 | 2018 | 3 | 0.200 |
Why?
|
Interleukin-6 | 4 | 2015 | 225 | 0.190 |
Why?
|
INDEL Mutation | 2 | 2018 | 10 | 0.190 |
Why?
|
Repressor Proteins | 2 | 2017 | 53 | 0.190 |
Why?
|
Bayes Theorem | 5 | 2019 | 67 | 0.190 |
Why?
|
HLA-C Antigens | 2 | 2017 | 3 | 0.190 |
Why?
|
Insulin-Secreting Cells | 2 | 2018 | 53 | 0.190 |
Why?
|
Blood Pressure Determination | 2 | 2017 | 94 | 0.180 |
Why?
|
Microsatellite Repeats | 4 | 2014 | 25 | 0.180 |
Why?
|
Reference Values | 6 | 2019 | 224 | 0.180 |
Why?
|
Mutation, Missense | 4 | 2014 | 48 | 0.180 |
Why?
|
Fasting | 3 | 2016 | 93 | 0.180 |
Why?
|
Carotid Arteries | 3 | 2015 | 97 | 0.180 |
Why?
|
Ultrasonography | 4 | 2019 | 345 | 0.180 |
Why?
|
Heart | 4 | 2009 | 161 | 0.180 |
Why?
|
OX40 Ligand | 3 | 2016 | 6 | 0.180 |
Why?
|
Cholesterol Ester Transfer Proteins | 2 | 2016 | 11 | 0.180 |
Why?
|
PPAR gamma | 2 | 2011 | 45 | 0.180 |
Why?
|
Sequence Deletion | 2 | 2017 | 36 | 0.180 |
Why?
|
TCF Transcription Factors | 3 | 2008 | 8 | 0.180 |
Why?
|
Base Sequence | 5 | 2012 | 240 | 0.180 |
Why?
|
Aspartate Aminotransferases | 1 | 2019 | 28 | 0.180 |
Why?
|
Alanine Transaminase | 1 | 2019 | 44 | 0.180 |
Why?
|
Antigens, Nuclear | 1 | 2019 | 6 | 0.180 |
Why?
|
Enoyl-CoA Hydratase | 1 | 2019 | 4 | 0.180 |
Why?
|
Twins, Monozygotic | 1 | 2019 | 11 | 0.180 |
Why?
|
Sphingosine | 1 | 2019 | 13 | 0.180 |
Why?
|
Proportional Hazards Models | 6 | 2017 | 709 | 0.180 |
Why?
|
Scleroderma, Systemic | 1 | 2019 | 7 | 0.170 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2019 | 15 | 0.170 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 2019 | 7 | 0.170 |
Why?
|
Hematoma | 1 | 2019 | 23 | 0.170 |
Why?
|
Diseases in Twins | 1 | 2019 | 13 | 0.170 |
Why?
|
Kidney Function Tests | 5 | 2019 | 102 | 0.170 |
Why?
|
Constipation | 1 | 2019 | 12 | 0.170 |
Why?
|
Lysophospholipids | 1 | 2019 | 25 | 0.170 |
Why?
|
Animals | 14 | 2017 | 7297 | 0.170 |
Why?
|
Myositis, Inclusion Body | 1 | 2019 | 7 | 0.170 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 2 | 2017 | 4 | 0.170 |
Why?
|
Cholesterol, LDL | 4 | 2019 | 157 | 0.170 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 60 | 0.170 |
Why?
|
DNA Repair | 1 | 2019 | 50 | 0.170 |
Why?
|
Withholding Treatment | 1 | 2018 | 11 | 0.170 |
Why?
|
Urinary Bladder | 2 | 2019 | 164 | 0.170 |
Why?
|
Radiation Injuries | 1 | 2019 | 67 | 0.170 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2018 | 11 | 0.170 |
Why?
|
Chi-Square Distribution | 6 | 2017 | 293 | 0.170 |
Why?
|
Anesthesia | 1 | 2019 | 65 | 0.170 |
Why?
|
Transferrin | 1 | 2018 | 32 | 0.170 |
Why?
|
Nerve Tissue Proteins | 4 | 2019 | 118 | 0.170 |
Why?
|
Tracheostomy | 1 | 2019 | 28 | 0.170 |
Why?
|
Mutation | 3 | 2017 | 466 | 0.170 |
Why?
|
Intracranial Embolism | 1 | 2018 | 13 | 0.170 |
Why?
|
Chromosomes, Human, Pair 20 | 2 | 2010 | 6 | 0.170 |
Why?
|
North Carolina | 10 | 2016 | 1423 | 0.170 |
Why?
|
Radiodermatitis | 1 | 2018 | 5 | 0.170 |
Why?
|
Colon | 1 | 2019 | 56 | 0.170 |
Why?
|
Recovery of Function | 2 | 2018 | 190 | 0.170 |
Why?
|
Rheumatoid Factor | 1 | 2018 | 4 | 0.160 |
Why?
|
Healthcare Disparities | 2 | 2017 | 153 | 0.160 |
Why?
|
Respiration, Artificial | 1 | 2019 | 96 | 0.160 |
Why?
|
beta Karyopherins | 2 | 2016 | 7 | 0.160 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2017 | 53 | 0.160 |
Why?
|
Peripheral Nerves | 1 | 2019 | 58 | 0.160 |
Why?
|
Dipeptidases | 2 | 2009 | 5 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 126 | 0.160 |
Why?
|
Mice | 8 | 2017 | 2368 | 0.160 |
Why?
|
Nuclear Proteins | 3 | 2017 | 71 | 0.160 |
Why?
|
Cosmic Radiation | 1 | 2018 | 13 | 0.160 |
Why?
|
Retrospective Studies | 8 | 2019 | 3111 | 0.160 |
Why?
|
Hematopoiesis | 1 | 2018 | 34 | 0.160 |
Why?
|
Long QT Syndrome | 2 | 2009 | 39 | 0.160 |
Why?
|
Tunica Intima | 4 | 2013 | 59 | 0.160 |
Why?
|
Saliva | 1 | 2018 | 36 | 0.160 |
Why?
|
Metabolome | 1 | 2018 | 31 | 0.160 |
Why?
|
Islets of Langerhans | 2 | 2016 | 74 | 0.160 |
Why?
|
Leukocytes | 1 | 2018 | 52 | 0.160 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2018 | 47 | 0.160 |
Why?
|
Neoplasm Proteins | 3 | 2013 | 141 | 0.160 |
Why?
|
Selection, Genetic | 2 | 2015 | 11 | 0.160 |
Why?
|
ROC Curve | 6 | 2018 | 149 | 0.160 |
Why?
|
Nursing Staff, Hospital | 1 | 2017 | 10 | 0.160 |
Why?
|
Software | 2 | 2012 | 109 | 0.160 |
Why?
|
Medical Staff, Hospital | 1 | 2017 | 18 | 0.160 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 16 | 0.160 |
Why?
|
Demography | 5 | 2017 | 104 | 0.160 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2017 | 23 | 0.160 |
Why?
|
Heart Block | 1 | 2017 | 9 | 0.160 |
Why?
|
Calpain | 1 | 2017 | 12 | 0.160 |
Why?
|
Methylamines | 1 | 2017 | 2 | 0.160 |
Why?
|
Oxygenases | 1 | 2017 | 3 | 0.160 |
Why?
|
Peroxidase | 1 | 2017 | 33 | 0.150 |
Why?
|
Anticoagulants | 1 | 2018 | 120 | 0.150 |
Why?
|
Mutagenesis, Insertional | 1 | 2017 | 14 | 0.150 |
Why?
|
Health Status Disparities | 2 | 2016 | 113 | 0.150 |
Why?
|
Ultrafiltration | 1 | 2017 | 9 | 0.150 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 35 | 0.150 |
Why?
|
Cause of Death | 2 | 2015 | 220 | 0.150 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 114 | 0.150 |
Why?
|
Platelet Transfusion | 1 | 2017 | 16 | 0.150 |
Why?
|
Mendelian Randomization Analysis | 1 | 2017 | 12 | 0.150 |
Why?
|
Tamoxifen | 1 | 2017 | 48 | 0.150 |
Why?
|
Zinc Fingers | 1 | 2017 | 8 | 0.150 |
Why?
|
Models, Statistical | 4 | 2012 | 163 | 0.150 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 2008 | 11 | 0.150 |
Why?
|
Longitudinal Studies | 5 | 2018 | 720 | 0.150 |
Why?
|
Intra-Abdominal Fat | 7 | 2013 | 61 | 0.150 |
Why?
|
Regression Analysis | 3 | 2006 | 274 | 0.150 |
Why?
|
Creatinine | 6 | 2017 | 174 | 0.150 |
Why?
|
Pelvic Pain | 1 | 2017 | 18 | 0.150 |
Why?
|
Hypotension | 1 | 2017 | 47 | 0.150 |
Why?
|
Environmental Exposure | 1 | 2017 | 87 | 0.150 |
Why?
|
Mitochondrial Diseases | 1 | 2016 | 11 | 0.150 |
Why?
|
Excitatory Amino Acid Transporter 1 | 1 | 2016 | 3 | 0.150 |
Why?
|
Receptor, EphB2 | 1 | 2016 | 6 | 0.150 |
Why?
|
Pain | 1 | 2019 | 282 | 0.150 |
Why?
|
NFI Transcription Factors | 1 | 2016 | 12 | 0.150 |
Why?
|
Laminin | 1 | 2016 | 13 | 0.150 |
Why?
|
Neurosurgical Procedures | 1 | 2017 | 98 | 0.140 |
Why?
|
Statistics, Nonparametric | 4 | 2017 | 129 | 0.140 |
Why?
|
Time Factors | 7 | 2017 | 2001 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2016 | 6 | 0.140 |
Why?
|
Pulmonary Fibrosis | 1 | 2016 | 10 | 0.140 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 11 | 0.140 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 26 | 0.140 |
Why?
|
Rheumatology | 1 | 2016 | 7 | 0.140 |
Why?
|
Mesenchymal Stem Cells | 1 | 2018 | 161 | 0.140 |
Why?
|
Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2016 | 5 | 0.140 |
Why?
|
Cerebral Ventricles | 1 | 2016 | 11 | 0.140 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 12 | 0.140 |
Why?
|
Spinal Fractures | 1 | 2016 | 42 | 0.140 |
Why?
|
Parathyroid Hormone | 1 | 2016 | 38 | 0.140 |
Why?
|
Judgment | 1 | 2015 | 11 | 0.140 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2013 | 4 | 0.140 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 6 | 0.140 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2015 | 4 | 0.140 |
Why?
|
Open Reading Frames | 2 | 2014 | 18 | 0.140 |
Why?
|
Likelihood Functions | 5 | 2017 | 39 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 50 | 0.140 |
Why?
|
DNA, Mitochondrial | 1 | 2015 | 28 | 0.140 |
Why?
|
Dementia | 2 | 2017 | 234 | 0.140 |
Why?
|
Urinary Incontinence | 1 | 2016 | 45 | 0.130 |
Why?
|
Receptors, Interleukin | 2 | 2013 | 15 | 0.130 |
Why?
|
Respiratory System | 1 | 2015 | 12 | 0.130 |
Why?
|
Leptin | 1 | 2015 | 66 | 0.130 |
Why?
|
Gene Expression | 3 | 2017 | 332 | 0.130 |
Why?
|
Anemia, Sickle Cell | 1 | 2015 | 39 | 0.130 |
Why?
|
Complement Factor H | 2 | 2014 | 5 | 0.130 |
Why?
|
Anticonvulsants | 1 | 2015 | 63 | 0.130 |
Why?
|
Caveolin 1 | 1 | 2015 | 13 | 0.130 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 51 | 0.130 |
Why?
|
Collagen Type IV | 1 | 2015 | 8 | 0.130 |
Why?
|
Stress, Physiological | 1 | 2015 | 44 | 0.130 |
Why?
|
Immunity, Innate | 2 | 2012 | 64 | 0.130 |
Why?
|
Interleukins | 2 | 2013 | 17 | 0.130 |
Why?
|
DNA Primers | 5 | 2009 | 87 | 0.130 |
Why?
|
Muscle, Smooth | 1 | 2015 | 73 | 0.130 |
Why?
|
Exercise | 2 | 2019 | 591 | 0.130 |
Why?
|
Spectrin | 1 | 2014 | 5 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 208 | 0.130 |
Why?
|
Trachea | 1 | 2015 | 55 | 0.130 |
Why?
|
Meta-Analysis as Topic | 4 | 2018 | 39 | 0.130 |
Why?
|
Hippocampus | 1 | 2016 | 185 | 0.130 |
Why?
|
Protein Binding | 4 | 2019 | 199 | 0.130 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2017 | 179 | 0.130 |
Why?
|
Mutant Chimeric Proteins | 1 | 2014 | 5 | 0.130 |
Why?
|
Receptors, Complement 3d | 1 | 2014 | 11 | 0.130 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 7 | 0.130 |
Why?
|
HMGA2 Protein | 1 | 2014 | 13 | 0.130 |
Why?
|
Arachidonic Acid | 2 | 2011 | 35 | 0.130 |
Why?
|
Interleukin-2 | 2 | 2011 | 33 | 0.130 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 311 | 0.130 |
Why?
|
Muscle Proteins | 2 | 2019 | 57 | 0.130 |
Why?
|
Computer Simulation | 3 | 2012 | 207 | 0.130 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2014 | 13 | 0.120 |
Why?
|
Cell Differentiation | 1 | 2016 | 436 | 0.120 |
Why?
|
Biomedical Research | 1 | 2016 | 153 | 0.120 |
Why?
|
Metabolic Clearance Rate | 1 | 2014 | 17 | 0.120 |
Why?
|
src-Family Kinases | 1 | 2014 | 16 | 0.120 |
Why?
|
Kidney | 3 | 2013 | 485 | 0.120 |
Why?
|
Molecular Sequence Data | 5 | 2016 | 350 | 0.120 |
Why?
|
Monocytes | 1 | 2015 | 119 | 0.120 |
Why?
|
Selenoprotein P | 1 | 2013 | 2 | 0.120 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2013 | 3 | 0.120 |
Why?
|
Antibodies, Anticardiolipin | 2 | 2013 | 4 | 0.120 |
Why?
|
Genetic Heterogeneity | 2 | 2004 | 13 | 0.120 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2013 | 5 | 0.120 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 24 | 0.120 |
Why?
|
Autoantigens | 1 | 2013 | 16 | 0.120 |
Why?
|
Interleukin-10 | 1 | 2013 | 30 | 0.120 |
Why?
|
Receptors, IgG | 2 | 2004 | 7 | 0.120 |
Why?
|
Interleukin-1 | 2 | 2003 | 33 | 0.120 |
Why?
|
Glucuronosyltransferase | 1 | 2013 | 5 | 0.120 |
Why?
|
Transcription, Genetic | 1 | 2014 | 136 | 0.120 |
Why?
|
Lung Neoplasms | 1 | 2017 | 384 | 0.120 |
Why?
|
Infant, Newborn | 5 | 2017 | 598 | 0.120 |
Why?
|
Proteins | 2 | 2017 | 140 | 0.120 |
Why?
|
Haptoglobins | 1 | 2013 | 4 | 0.110 |
Why?
|
Toll-Like Receptor 7 | 1 | 2013 | 11 | 0.110 |
Why?
|
Bilirubin | 1 | 2013 | 22 | 0.110 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 2010 | 15 | 0.110 |
Why?
|
Tomography, Spiral Computed | 1 | 2013 | 18 | 0.110 |
Why?
|
Polymerase Chain Reaction | 5 | 2014 | 172 | 0.110 |
Why?
|
Selenoproteins | 1 | 2012 | 3 | 0.110 |
Why?
|
Indians, South American | 1 | 2012 | 2 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 152 | 0.110 |
Why?
|
Exons | 5 | 2014 | 49 | 0.110 |
Why?
|
Actinin | 1 | 2012 | 4 | 0.110 |
Why?
|
Methyl-CpG-Binding Protein 2 | 1 | 2012 | 2 | 0.110 |
Why?
|
SOXF Transcription Factors | 1 | 2012 | 4 | 0.110 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 10 | 0.110 |
Why?
|
Comorbidity | 5 | 2017 | 540 | 0.110 |
Why?
|
Life Style | 4 | 2019 | 364 | 0.110 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 47 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 1218 | 0.110 |
Why?
|
Egg Proteins | 1 | 2012 | 2 | 0.110 |
Why?
|
Ikaros Transcription Factor | 1 | 2012 | 2 | 0.110 |
Why?
|
HLA-DR2 Antigen | 2 | 2014 | 3 | 0.110 |
Why?
|
HLA-DR3 Antigen | 2 | 2014 | 3 | 0.110 |
Why?
|
Calcium | 3 | 2010 | 296 | 0.110 |
Why?
|
Heart Ventricles | 1 | 2013 | 107 | 0.110 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2012 | 5 | 0.110 |
Why?
|
Mice, Inbred C57BL | 4 | 2017 | 711 | 0.110 |
Why?
|
Multiprotein Complexes | 1 | 2011 | 16 | 0.100 |
Why?
|
Interferon-alpha | 1 | 2012 | 69 | 0.100 |
Why?
|
Linear Models | 4 | 2019 | 426 | 0.100 |
Why?
|
Protein Phosphatase 2 | 1 | 2011 | 5 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2011 | 980 | 0.100 |
Why?
|
Myocardium | 1 | 2012 | 170 | 0.100 |
Why?
|
Hemoglobin, Sickle | 1 | 2011 | 7 | 0.100 |
Why?
|
Artificial Intelligence | 1 | 2012 | 49 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2016 | 514 | 0.100 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2011 | 10 | 0.100 |
Why?
|
Interferons | 1 | 2011 | 17 | 0.100 |
Why?
|
Sickle Cell Trait | 1 | 2011 | 12 | 0.100 |
Why?
|
Lipoproteins | 2 | 2009 | 82 | 0.100 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2011 | 14 | 0.100 |
Why?
|
Protein-Serine-Threonine Kinases | 2 | 2010 | 44 | 0.100 |
Why?
|
Models, Molecular | 1 | 2011 | 178 | 0.100 |
Why?
|
Aorta, Abdominal | 2 | 2011 | 26 | 0.100 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2011 | 29 | 0.100 |
Why?
|
Antigens, Neoplasm | 1 | 2011 | 44 | 0.100 |
Why?
|
Cognition Disorders | 1 | 2014 | 390 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2011 | 12 | 0.100 |
Why?
|
Siblings | 4 | 2017 | 24 | 0.100 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2010 | 13 | 0.100 |
Why?
|
RGS Proteins | 1 | 2011 | 18 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 83 | 0.100 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2010 | 7 | 0.100 |
Why?
|
Diet | 3 | 2011 | 354 | 0.100 |
Why?
|
Genes, Dominant | 3 | 2008 | 26 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2011 | 53 | 0.100 |
Why?
|
Food Preferences | 1 | 2011 | 35 | 0.100 |
Why?
|
Neoplasms | 1 | 2017 | 610 | 0.100 |
Why?
|
Apoptosis | 1 | 2012 | 337 | 0.100 |
Why?
|
Trypanosoma brucei rhodesiense | 1 | 2010 | 2 | 0.100 |
Why?
|
MicroRNAs | 1 | 2013 | 173 | 0.100 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2010 | 3 | 0.100 |
Why?
|
Interferon Type I | 1 | 2010 | 14 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 67 | 0.090 |
Why?
|
Graft Rejection | 1 | 2011 | 149 | 0.090 |
Why?
|
Americas | 2 | 2010 | 5 | 0.090 |
Why?
|
Glucuronidase | 1 | 2010 | 9 | 0.090 |
Why?
|
Dietary Fats | 1 | 2011 | 108 | 0.090 |
Why?
|
Stroke Volume | 1 | 2013 | 278 | 0.090 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2010 | 21 | 0.090 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2010 | 13 | 0.090 |
Why?
|
Isoenzymes | 1 | 2010 | 63 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2010 | 58 | 0.090 |
Why?
|
Complement C1q | 1 | 2010 | 4 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2005 | 441 | 0.090 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2009 | 6 | 0.090 |
Why?
|
Neutrophils | 2 | 2009 | 102 | 0.090 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2012 | 41 | 0.090 |
Why?
|
HLA-DQ Antigens | 2 | 2016 | 9 | 0.090 |
Why?
|
I-kappa B Proteins | 1 | 2009 | 10 | 0.090 |
Why?
|
Survival Rate | 3 | 2019 | 795 | 0.090 |
Why?
|
Heart Diseases | 1 | 2010 | 97 | 0.090 |
Why?
|
Bone Morphogenetic Protein 7 | 1 | 2009 | 18 | 0.090 |
Why?
|
Interleukin-21 Receptor alpha Subunit | 1 | 2009 | 1 | 0.090 |
Why?
|
Entropy | 1 | 2009 | 8 | 0.090 |
Why?
|
Photosensitivity Disorders | 1 | 2009 | 11 | 0.090 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2009 | 13 | 0.090 |
Why?
|
Databases, Genetic | 3 | 2018 | 35 | 0.090 |
Why?
|
Receptors, Somatostatin | 1 | 2009 | 5 | 0.090 |
Why?
|
Blood Vessels | 1 | 2009 | 47 | 0.090 |
Why?
|
Immediate-Early Proteins | 1 | 2009 | 9 | 0.090 |
Why?
|
Calcium-Binding Proteins | 2 | 2019 | 45 | 0.090 |
Why?
|
KCNQ2 Potassium Channel | 1 | 2009 | 3 | 0.090 |
Why?
|
Cells, Cultured | 3 | 2019 | 799 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 3 | 0.090 |
Why?
|
Sodium Channels | 1 | 2009 | 13 | 0.090 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 23 | 0.080 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2008 | 9 | 0.080 |
Why?
|
Anemia, Hemolytic | 1 | 2008 | 6 | 0.080 |
Why?
|
Tunica Media | 2 | 2013 | 29 | 0.080 |
Why?
|
Gene Regulatory Networks | 2 | 2019 | 35 | 0.080 |
Why?
|
Ephrin-B2 | 1 | 2008 | 2 | 0.080 |
Why?
|
Epoxide Hydrolases | 1 | 2008 | 5 | 0.080 |
Why?
|
Organ Specificity | 2 | 2019 | 77 | 0.080 |
Why?
|
CpG Islands | 2 | 2019 | 44 | 0.080 |
Why?
|
Radiotherapy | 2 | 2019 | 74 | 0.080 |
Why?
|
Diabetes Mellitus | 3 | 2010 | 366 | 0.080 |
Why?
|
Intraocular Pressure | 2 | 2018 | 25 | 0.080 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2008 | 6 | 0.080 |
Why?
|
Cyclooxygenase 2 | 1 | 2008 | 50 | 0.080 |
Why?
|
Calcitriol | 1 | 2008 | 23 | 0.080 |
Why?
|
Pyrophosphatases | 1 | 2008 | 3 | 0.080 |
Why?
|
Signal Transduction | 3 | 2019 | 666 | 0.080 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2008 | 10 | 0.080 |
Why?
|
Absorptiometry, Photon | 2 | 2005 | 129 | 0.080 |
Why?
|
Proprotein Convertase 2 | 1 | 2007 | 2 | 0.080 |
Why?
|
Iron | 2 | 2018 | 113 | 0.080 |
Why?
|
Coenzyme A Ligases | 1 | 2007 | 2 | 0.080 |
Why?
|
Receptors, Fc | 1 | 2007 | 6 | 0.080 |
Why?
|
Adult Children | 2 | 2003 | 4 | 0.080 |
Why?
|
Immunoglobulin A | 1 | 2007 | 9 | 0.080 |
Why?
|
Asian Americans | 3 | 2013 | 98 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2019 | 532 | 0.070 |
Why?
|
Trinucleotide Repeats | 1 | 2007 | 9 | 0.070 |
Why?
|
Leucine | 1 | 2007 | 24 | 0.070 |
Why?
|
Carotid Artery, Common | 2 | 2004 | 37 | 0.070 |
Why?
|
Blood Proteins | 1 | 2006 | 18 | 0.070 |
Why?
|
Cholesterol | 3 | 2019 | 229 | 0.070 |
Why?
|
Lymphotoxin-alpha | 1 | 2006 | 4 | 0.070 |
Why?
|
Antigens, CD | 1 | 2007 | 100 | 0.070 |
Why?
|
Blotting, Western | 2 | 2019 | 281 | 0.070 |
Why?
|
CD40 Ligand | 1 | 2006 | 13 | 0.070 |
Why?
|
Argentina | 2 | 2016 | 5 | 0.070 |
Why?
|
Peru | 2 | 2016 | 19 | 0.070 |
Why?
|
Pollen | 1 | 2006 | 2 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2006 | 68 | 0.070 |
Why?
|
Pro-Opiomelanocortin | 1 | 2005 | 1 | 0.070 |
Why?
|
Hypersensitivity | 1 | 2006 | 25 | 0.070 |
Why?
|
P-Selectin | 1 | 2005 | 10 | 0.070 |
Why?
|
Body Weight | 2 | 2003 | 290 | 0.070 |
Why?
|
Genome Components | 1 | 2005 | 2 | 0.070 |
Why?
|
Receptors, Opioid, mu | 1 | 2005 | 51 | 0.070 |
Why?
|
Leukoaraiosis | 1 | 2004 | 2 | 0.070 |
Why?
|
Ohio | 2 | 2017 | 54 | 0.070 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 36 | 0.070 |
Why?
|
Carcinoma | 1 | 2005 | 87 | 0.060 |
Why?
|
Phosphoproteins | 1 | 2005 | 54 | 0.060 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 11 | 0.060 |
Why?
|
Diabetic Foot | 1 | 2004 | 19 | 0.060 |
Why?
|
Preventive Health Services | 1 | 2004 | 30 | 0.060 |
Why?
|
Statistical Distributions | 1 | 2004 | 5 | 0.060 |
Why?
|
Electrocardiography | 4 | 2013 | 562 | 0.060 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 2 | 2016 | 4 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2017 | 425 | 0.060 |
Why?
|
Renal Artery | 1 | 2004 | 43 | 0.060 |
Why?
|
Sample Size | 1 | 2004 | 37 | 0.060 |
Why?
|
Penetrance | 1 | 2003 | 3 | 0.060 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2003 | 7 | 0.060 |
Why?
|
Radioimmunoassay | 1 | 2004 | 21 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 27 | 0.060 |
Why?
|
Hypersensitivity, Immediate | 1 | 2003 | 9 | 0.060 |
Why?
|
3' Untranslated Regions | 3 | 2013 | 25 | 0.060 |
Why?
|
Patient Selection | 2 | 2019 | 257 | 0.060 |
Why?
|
Thrombocytopenia | 2 | 2017 | 32 | 0.060 |
Why?
|
Immunoglobulin E | 1 | 2003 | 47 | 0.060 |
Why?
|
Thoracic Vertebrae | 1 | 2004 | 42 | 0.060 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 280 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 66 | 0.060 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2003 | 5 | 0.060 |
Why?
|
Abdomen | 1 | 2003 | 42 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2009 | 454 | 0.060 |
Why?
|
NF-kappa B | 2 | 2013 | 75 | 0.060 |
Why?
|
Waist Circumference | 2 | 2016 | 89 | 0.060 |
Why?
|
Internet | 1 | 2004 | 156 | 0.060 |
Why?
|
Biopsy | 2 | 2016 | 241 | 0.060 |
Why?
|
Apolipoproteins B | 1 | 2003 | 44 | 0.060 |
Why?
|
Liver | 2 | 2019 | 464 | 0.060 |
Why?
|
HLA-DR Antigens | 1 | 2002 | 8 | 0.060 |
Why?
|
Systole | 2 | 2018 | 87 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2004 | 154 | 0.050 |
Why?
|
Hyperlipidemias | 1 | 2003 | 50 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2017 | 17 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 787 | 0.050 |
Why?
|
Bone Morphogenetic Protein 4 | 2 | 2013 | 13 | 0.050 |
Why?
|
RNA-Binding Proteins | 2 | 2015 | 68 | 0.050 |
Why?
|
8,11,14-Eicosatrienoic Acid | 2 | 2011 | 11 | 0.050 |
Why?
|
Africa | 2 | 2011 | 23 | 0.050 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2006 | 18 | 0.050 |
Why?
|
Lumbar Vertebrae | 2 | 2016 | 98 | 0.050 |
Why?
|
Trypanosomiasis, African | 2 | 2010 | 7 | 0.050 |
Why?
|
tRNA Methyltransferases | 2 | 2012 | 5 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2012 | 6 | 0.050 |
Why?
|
Age Distribution | 3 | 2007 | 198 | 0.050 |
Why?
|
Body Weights and Measures | 2 | 2011 | 22 | 0.050 |
Why?
|
Probability | 2 | 2011 | 150 | 0.050 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2019 | 3 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor B | 1 | 2019 | 5 | 0.040 |
Why?
|
gamma-Glutamyltransferase | 1 | 2019 | 9 | 0.040 |
Why?
|
Infant | 2 | 2017 | 969 | 0.040 |
Why?
|
Inheritance Patterns | 1 | 2019 | 10 | 0.040 |
Why?
|
Area Under Curve | 2 | 2011 | 85 | 0.040 |
Why?
|
BK Virus | 1 | 2019 | 7 | 0.040 |
Why?
|
Water | 1 | 2019 | 50 | 0.040 |
Why?
|
Brazil | 1 | 2019 | 13 | 0.040 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2018 | 2 | 0.040 |
Why?
|
Amino Acid Oxidoreductases | 1 | 2018 | 4 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 1 | 2019 | 33 | 0.040 |
Why?
|
Forearm | 1 | 2019 | 33 | 0.040 |
Why?
|
Environment | 1 | 2019 | 51 | 0.040 |
Why?
|
Observer Variation | 1 | 2019 | 96 | 0.040 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2018 | 1 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 64 | 0.040 |
Why?
|
Virus Replication | 1 | 2019 | 47 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2019 | 281 | 0.040 |
Why?
|
Ferritins | 1 | 2018 | 46 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 73 | 0.040 |
Why?
|
Down-Regulation | 1 | 2019 | 143 | 0.040 |
Why?
|
Solar Energy | 1 | 2018 | 4 | 0.040 |
Why?
|
Bystander Effect | 1 | 2018 | 6 | 0.040 |
Why?
|
Binding Sites | 1 | 2018 | 125 | 0.040 |
Why?
|
Protons | 1 | 2018 | 23 | 0.040 |
Why?
|
Homozygote | 2 | 2010 | 57 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 109 | 0.040 |
Why?
|
Body Constitution | 1 | 2018 | 26 | 0.040 |
Why?
|
Visual Fields | 1 | 2018 | 25 | 0.040 |
Why?
|
Aging | 1 | 2004 | 881 | 0.040 |
Why?
|
Metabolomics | 1 | 2018 | 45 | 0.040 |
Why?
|
Models, Biological | 2 | 2011 | 373 | 0.040 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2017 | 3 | 0.040 |
Why?
|
Janus Kinase 1 | 1 | 2017 | 4 | 0.040 |
Why?
|
High Mobility Group Proteins | 1 | 2017 | 7 | 0.040 |
Why?
|
Fathers | 1 | 2017 | 11 | 0.040 |
Why?
|
Diastole | 1 | 2018 | 90 | 0.040 |
Why?
|
Gene Deletion | 2 | 2011 | 64 | 0.040 |
Why?
|
DNA Damage | 1 | 2018 | 88 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2017 | 16 | 0.040 |
Why?
|
Kentucky | 1 | 2017 | 15 | 0.040 |
Why?
|
Visual Acuity | 1 | 2018 | 66 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2017 | 11 | 0.040 |
Why?
|
Ventriculostomy | 1 | 2017 | 11 | 0.040 |
Why?
|
Cell Line | 1 | 2018 | 449 | 0.040 |
Why?
|
Pharmacogenetics | 1 | 2017 | 35 | 0.040 |
Why?
|
Telomere | 1 | 2017 | 10 | 0.040 |
Why?
|
Alcohol-Related Disorders | 1 | 2017 | 22 | 0.040 |
Why?
|
Seasons | 2 | 2009 | 84 | 0.040 |
Why?
|
Receptors, Cell Surface | 1 | 2017 | 72 | 0.040 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 1 | 0.040 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2017 | 1 | 0.040 |
Why?
|
Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 1 | 0.040 |
Why?
|
Compliance | 1 | 2017 | 12 | 0.040 |
Why?
|
Somatomedins | 1 | 2017 | 5 | 0.040 |
Why?
|
Hedgehog Proteins | 1 | 2017 | 11 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 298 | 0.040 |
Why?
|
Glycosaminoglycans | 1 | 2017 | 20 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 69 | 0.040 |
Why?
|
Proteinuria | 2 | 2010 | 57 | 0.040 |
Why?
|
Radiography | 2 | 2010 | 353 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2017 | 89 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2018 | 139 | 0.040 |
Why?
|
Proteoglycans | 1 | 2017 | 29 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2017 | 67 | 0.040 |
Why?
|
Glycoproteins | 1 | 2017 | 34 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 82 | 0.040 |
Why?
|
Public Health | 1 | 2017 | 73 | 0.040 |
Why?
|
Mothers | 1 | 2017 | 79 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2017 | 110 | 0.040 |
Why?
|
Pain Measurement | 1 | 2018 | 364 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 16 | 0.040 |
Why?
|
Genes, Recessive | 2 | 2008 | 9 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2017 | 39 | 0.040 |
Why?
|
Republic of Korea | 1 | 2016 | 8 | 0.040 |
Why?
|
Osteoblasts | 1 | 2016 | 46 | 0.040 |
Why?
|
Mortality | 1 | 2017 | 109 | 0.040 |
Why?
|
Chile | 1 | 2016 | 6 | 0.040 |
Why?
|
Skin | 1 | 2018 | 203 | 0.040 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2016 | 8 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2017 | 249 | 0.040 |
Why?
|
Mexico | 1 | 2016 | 63 | 0.040 |
Why?
|
Colombia | 1 | 2015 | 2 | 0.030 |
Why?
|
South America | 1 | 2015 | 3 | 0.030 |
Why?
|
Length of Stay | 1 | 2017 | 292 | 0.030 |
Why?
|
Phosphates | 1 | 2015 | 25 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2008 | 140 | 0.030 |
Why?
|
Iliac Artery | 1 | 2015 | 46 | 0.030 |
Why?
|
Factor XIII | 1 | 2015 | 3 | 0.030 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2015 | 5 | 0.030 |
Why?
|
Physician's Role | 1 | 2015 | 38 | 0.030 |
Why?
|
Waist-Hip Ratio | 2 | 2005 | 33 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2015 | 19 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2015 | 55 | 0.030 |
Why?
|
Tissue and Organ Procurement | 1 | 2016 | 69 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2015 | 41 | 0.030 |
Why?
|
Incidence | 2 | 2011 | 1119 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2014 | 6 | 0.030 |
Why?
|
Survival Analysis | 1 | 2016 | 440 | 0.030 |
Why?
|
Donor Selection | 1 | 2015 | 31 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2015 | 51 | 0.030 |
Why?
|
Receptors, Complement 3b | 1 | 2014 | 7 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 248 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 337 | 0.030 |
Why?
|
Phosphorylation | 1 | 2015 | 225 | 0.030 |
Why?
|
North America | 2 | 2004 | 33 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2014 | 28 | 0.030 |
Why?
|
B-Lymphocyte Subsets | 1 | 2014 | 18 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2014 | 12 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2015 | 379 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2014 | 17 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 374 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2016 | 157 | 0.030 |
Why?
|
Renin-Angiotensin System | 1 | 2015 | 182 | 0.030 |
Why?
|
Angiotensinogen | 1 | 2014 | 73 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 464 | 0.030 |
Why?
|
Sp3 Transcription Factor | 1 | 2013 | 1 | 0.030 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2013 | 8 | 0.030 |
Why?
|
Lysophospholipase | 1 | 2013 | 5 | 0.030 |
Why?
|
Quality of Life | 1 | 2019 | 816 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2013 | 10 | 0.030 |
Why?
|
Receptors, Adiponectin | 1 | 2013 | 3 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 82 | 0.030 |
Why?
|
NADH Dehydrogenase | 1 | 2013 | 4 | 0.030 |
Why?
|
Receptors, CCR | 1 | 2013 | 1 | 0.030 |
Why?
|
Educational Status | 1 | 2014 | 164 | 0.030 |
Why?
|
Muramidase | 1 | 2013 | 8 | 0.030 |
Why?
|
Glutathione Reductase | 1 | 2013 | 9 | 0.030 |
Why?
|
Cystatin C | 1 | 2013 | 28 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2013 | 17 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2013 | 52 | 0.030 |
Why?
|
Bone Resorption | 1 | 2013 | 13 | 0.030 |
Why?
|
Disease Susceptibility | 2 | 2003 | 53 | 0.030 |
Why?
|
DNA, Viral | 1 | 2013 | 39 | 0.030 |
Why?
|
Lymphocytes | 1 | 2013 | 53 | 0.030 |
Why?
|
Sex Distribution | 2 | 2004 | 186 | 0.030 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2013 | 13 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2013 | 104 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2012 | 13 | 0.030 |
Why?
|
Up-Regulation | 1 | 2013 | 183 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2012 | 1 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2012 | 17 | 0.030 |
Why?
|
Cheek | 1 | 2012 | 5 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 430 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 70 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2015 | 573 | 0.030 |
Why?
|
Morbidity | 1 | 2012 | 91 | 0.030 |
Why?
|
Fibrosis | 1 | 2012 | 102 | 0.030 |
Why?
|
Heredity | 1 | 2012 | 12 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2012 | 29 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2012 | 69 | 0.030 |
Why?
|
Ribonucleoproteins | 1 | 2012 | 13 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2012 | 13 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2012 | 8 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2011 | 1 | 0.030 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2011 | 4 | 0.030 |
Why?
|
Family Characteristics | 1 | 2012 | 32 | 0.030 |
Why?
|
Plasmids | 1 | 2011 | 48 | 0.030 |
Why?
|
California | 1 | 2011 | 60 | 0.030 |
Why?
|
Crohn Disease | 1 | 2011 | 25 | 0.030 |
Why?
|
Asia | 1 | 2011 | 17 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 20 | 0.030 |
Why?
|
Oral Ulcer | 1 | 2011 | 5 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2011 | 17 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2011 | 12 | 0.030 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2011 | 8 | 0.030 |
Why?
|
Eicosapentaenoic Acid | 1 | 2011 | 26 | 0.030 |
Why?
|
Bronchi | 1 | 2011 | 41 | 0.030 |
Why?
|
Saint Kitts and Nevis | 1 | 2011 | 3 | 0.030 |
Why?
|
DNA, Intergenic | 1 | 2011 | 9 | 0.020 |
Why?
|
Autopsy | 1 | 2011 | 37 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 391 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 158 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 20 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2011 | 114 | 0.020 |
Why?
|
Phosphorus | 1 | 2010 | 11 | 0.020 |
Why?
|
Skin Physiological Phenomena | 1 | 2010 | 7 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 2010 | 4 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 72 | 0.020 |
Why?
|
Japan | 1 | 2010 | 15 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2011 | 52 | 0.020 |
Why?
|
China | 1 | 2010 | 44 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 8 | 0.020 |
Why?
|
Nephrotic Syndrome | 1 | 2010 | 12 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 20 | 0.020 |
Why?
|
Urologic Diseases | 1 | 2010 | 28 | 0.020 |
Why?
|
Health Behavior | 1 | 2012 | 214 | 0.020 |
Why?
|
Kidney Tubules | 1 | 2010 | 25 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2009 | 21 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2010 | 248 | 0.020 |
Why?
|
Kidney Glomerulus | 1 | 2010 | 30 | 0.020 |
Why?
|
Particle Size | 1 | 2009 | 42 | 0.020 |
Why?
|
Aorta | 1 | 2010 | 103 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 339 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2009 | 22 | 0.020 |
Why?
|
Abdominal Fat | 1 | 2009 | 46 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2009 | 27 | 0.020 |
Why?
|
South Carolina | 1 | 2008 | 29 | 0.020 |
Why?
|
Receptors, Drug | 1 | 2008 | 14 | 0.020 |
Why?
|
25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2008 | 5 | 0.020 |
Why?
|
Urban Population | 1 | 2009 | 79 | 0.020 |
Why?
|
Receptors, Calcitriol | 1 | 2008 | 10 | 0.020 |
Why?
|
Vitamin D-Binding Protein | 1 | 2008 | 10 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2009 | 249 | 0.020 |
Why?
|
Cation Transport Proteins | 1 | 2008 | 24 | 0.020 |
Why?
|
Los Angeles | 1 | 2008 | 8 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2008 | 60 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2008 | 37 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2008 | 93 | 0.020 |
Why?
|
Southeastern United States | 1 | 2008 | 71 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 81 | 0.020 |
Why?
|
Rural Population | 1 | 2009 | 246 | 0.020 |
Why?
|
Cell Degranulation | 1 | 2007 | 4 | 0.020 |
Why?
|
Phagocytosis | 1 | 2007 | 9 | 0.020 |
Why?
|
Endocytosis | 1 | 2007 | 11 | 0.020 |
Why?
|
Carnosine | 1 | 2007 | 3 | 0.020 |
Why?
|
Hormone Replacement Therapy | 1 | 2007 | 86 | 0.020 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2006 | 13 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2008 | 126 | 0.020 |
Why?
|
Motor Activity | 1 | 2009 | 310 | 0.020 |
Why?
|
Physical Chromosome Mapping | 1 | 2006 | 8 | 0.020 |
Why?
|
Estrogens | 1 | 2007 | 162 | 0.020 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2005 | 13 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 4 | 1 | 2005 | 3 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 92 | 0.020 |
Why?
|
Postmenopause | 1 | 2007 | 397 | 0.020 |
Why?
|
Threonine | 1 | 2005 | 10 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2005 | 13 | 0.020 |
Why?
|
Viscera | 1 | 2005 | 17 | 0.020 |
Why?
|
Tissue Embedding | 1 | 2004 | 1 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2005 | 37 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2004 | 36 | 0.020 |
Why?
|
Solubility | 1 | 2004 | 38 | 0.020 |
Why?
|
Serum | 1 | 2004 | 20 | 0.020 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2004 | 9 | 0.020 |
Why?
|
Microcirculation | 1 | 2004 | 61 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2007 | 680 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2005 | 46 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 10 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 20 | 0.020 |
Why?
|
Cadaver | 1 | 2004 | 143 | 0.020 |
Why?
|
Energy Intake | 1 | 2005 | 120 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2004 | 36 | 0.020 |
Why?
|
Coronary Stenosis | 1 | 2004 | 28 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2005 | 130 | 0.020 |
Why?
|
Physical Examination | 1 | 2004 | 82 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2008 | 412 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2004 | 16 | 0.020 |
Why?
|
Skin Tests | 1 | 2003 | 15 | 0.020 |
Why?
|
Cysteine | 1 | 2005 | 131 | 0.020 |
Why?
|
Electrophoresis | 1 | 2003 | 7 | 0.010 |
Why?
|
Carotid Stenosis | 1 | 2004 | 56 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2004 | 141 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2004 | 242 | 0.010 |
Why?
|
Rats | 1 | 2007 | 1604 | 0.010 |
Why?
|
Founder Effect | 1 | 2002 | 4 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2002 | 20 | 0.010 |
Why?
|